Food and Drug Law Weekly

Academy of Managed Care Pharmacy - Academy of Managed Care Pharmacy 2008 Educational Conference Is Goin' To Kansas City!

Depomed, Inc. - Depomed Initiates Phase 3 Program in Menopausal Hot Flashes

Faith United Against Tobacco - North Carolina Faith Leaders Call on Sen. Burr to End Opposition to Legislation to Protect Kids From Tobacco

Food and Drug Law Institute - New FDLI Book Provides Comprehensive Guidance on Off-Label Communication

Generic Pharmaceutical Association (GPhA) - Senior Advisors to Presidential Candidates John McCain and Barack Obama Affirm Support for Increased Access to Generic Medicines and Creation of an FDA Approval Pathway for Biogenerics

Hoana Medical, Inc. - Hoana Medical Acquires CAN ISO and J-GMP Marks to Expand Patient Safety Technology to Canadian and Asian Market

NewsRx - NewsRx Launches Education Titles; Offers Free Global Warming Publication

Pfizer Inc - Pfizer Launches New Medicine Safety Website to Help Healthcare Professionals and Patients Make Better Informed Decisions about Treatment Options

28th Annual Modern Day Marine Military Exposition - Marine Military Expo to Premiere Robotics Obstacle Course

Adverse Drug Reactions - Investigators at Federal Institute for Drugs and Medical Devices have published new data on adverse drug reactions

American Chemistry Council - New Bisphenol a Study Has Limited Capability to Assess Human Health Effects

Anthrax - Research reports from Food & Drug Administration provide new insights into anthrax

Anthrax Vaccines - PharmAthene Response to DHHS Request for Proposals for Recombinant Protective Antigen Anthrax Vaccine Deemed Technically Acceptable and Within Competitive Range for Procurement Consideration

Association of Academic Health Centers - AAHC Releases Guide to Emergency Preparedness and Disaster Response

Aurora Imaging Technology Inc. - Breast MRI of the Main Line Makes Available the Aurora Dedicated Breast MRI System for Philadelphia Residents

Bausch & Lomb - FDA Approves Bausch & Lomb Akreos Advanced Optics Aspheric Lens

Biologics - FDA Issues Complete Response Letter to Roche for ACTEMRA(R) (tocilizumab) Biologics License Application

BioSante Pharmaceuticals, Inc. - Let's Get It On

Biotechnology Business - Preliminary Data From Experimental Study Demonstrate Increased Mortality in Stroke Patients Treated With Epoetin Alfa

Biovail Corporation - Biovail Acquires Prestwick Pharmaceuticals

Biowarfare - Shiraz University reports research in biowarfare

Cadence Pharmaceuticals, Inc. - Cadence Pharmaceuticals Updates Omigard(TM) Clinical Timeline

Cancer - Cephalon Receives Complete Response Letter Regarding Request for Expanded FENTORA Label for Non-Cancer Breakthrough Pain

Cancer - F.D.A. Approves SANCUSO(R), the First and Only Patch for Preventing Nausea and Vomiting in Cancer Patients Undergoing Chemotherapy

Cancer Gene Therapy - Epeius Biotechnologies' Lead Product, Rexin-G for Metastatic Cancer, Aptly Highlighted by National Cancer Institute Journal

CDISC - CDISC Awarded Contract for Training of FDA Reviewers

Charles River Laboratories International, Inc. - Charles River Acquires MIR Preclinical Services

Chronic Disease Gene Therapy - Researchers at University of Louisville, Department of Medicine target chronic disease gene therapy

Clinical Trial Research - Research on clinical trial research published by scientists at Hokuriku University, Faculty of Pharmaceutical Sciences

Clinical Trial Research - SemBioSys eligible to proceed with Phase I/II plant-produced insulin trial after submission of IND

Colon Cancer - New findings from K.S. Lovejoy and co-authors in the area of colon cancer published

CV Technologies Inc. - Colds and flu cut by one-third in study of Canada's top cold fighter in vaccinated seniors

Dengue Fever - Research from B.K.W. Koh and co-researchers in the area of dengue fever published

Drug Resistance - Reports from University of Buenos Aires highlight recent research in drug resistance

Emergent BioSolutions Inc. - Emergent BioSolutions Notified by HHS That Its Proposal to Provide 25 Million Doses of Its Recombinant Anthrax Vaccine Is Technically Acceptable and Within the Competitive Range

Encephalitis - New findings from L.E. Davis and co-authors describe advances in encephalitis

Enjoy Life Foods - Enjoy Life Foods CEO Tells FDA Grocery Stores Remain a Dangerous Minefield for Food Allergic, Food Intolerant and Celiac Shoppers

Escherichia Coli - Findings from University of Idaho broaden understanding of Escherichia coli

Escherichia Coli - Study findings from Purdue University provide new insights into Escherichia coli

European Society for Medical Oncology - Promising new treatment option for women with recurrent ovarian cancer

Gilead Sciences, Inc. - Gilead Receives Complete Response Letter from U.S. Food and Drug Administration for Aztreonam Lysine for Inhalation, an Investigational Treatment for Cystic Fibrosis

Glaucoma - SOLX Receives FDA 510(k) Clearance for New Glaucoma Laser

Heart Failure - Study data from S.G. Weeks and co-authors update knowledge of heart failure

Homeopathy - New homeopathy study findings recently were reported by E.A. Thompson and co-researchers

Hypertension - Daiichi Sankyo, Inc. Files Supplemental New Drug Application for AZOR(R) as Initial Therapy for High Blood Pressure

InNexus Biotechnology Inc. - InNexus Lead Candidate DXL625 Outperforms Rituxan in Additional Animal Studies

Intact Medical Corporation - Intact Medical Corporation's Intact(R) Excise XL Receives 510(K) Marketing Clearance from the FDA

Investor Environmental Health Network, Washington, D.C. - Report: Consumers, Manufacturers and Retailers Dumping BPA Plastics, Not Waiting for Regulators

JAMA and Archives Journals - Higher urinary levels of commonly used chemical, BPA, linked with cardiovascular disease, diabetes

Kidney Cancer - Latest RAD001 Study Results Show Further Increase in Time Without Tumor Growth in Patients With Advanced Kidney Cancer